Provision of subsidized malaria drugs in shops improves uptake

Reporting the findings of a cluster randomized trial carried out in rural Kenya, Beth Kangwana and colleagues find that provision of packs of the malaria therapy artemether-lumefantrine in shops at a subsidized price more than doubled the proportion of children with fever who received drugs promptly.

Importantly, whilst enabling cheap and easy purchase of in shops enabled treatment of about 44% of children with fever, this is still much lower than the target of treating 80% of children with fever set by the Roll Back Malaria Partnership.

So in addition to this type of pragmatic solution to the problem of access to drugs, additional strategies will be required to boost the numbers of children with who are treated with antimalarials.

More information: Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, et al. (2011) The Impact of Retail-Sector Delivery of Artemether–Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial. PLoS Med 8(5): e1000437. doi:10.1371/journal.pmed.1000437

add to favorites email to friend print save as pdf

Related Stories

Malaria makes relapsing fever more serious

May 08, 2009

Malaria and the Borrelia infection relapsing fever are diseases with similar symptoms that can occur simultaneously. In such cases, the malaria is moderated while the relapsing fever becomes more serious. This is shown in ...

How to treat fevers in African children up for debate

Jan 06, 2009

A new debate in the open access journal PLoS Medicine questions whether all African children with fever should be treated presumptively with antimalarial drugs, or if treatment should wait until laboratory tests confirm malari ...

Supplementary approach to malaria

Feb 05, 2008

Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments